The Optune device delivers electric Tumor Treating Fields (TTFields) and has had an established role for the treatment of recurrent and newly diagnosed glioblastoma since receiving FDA approvals in 2011 and 2015, respectively. Where this treatment modality goes from...
CITATION STYLE
Wong, E. T., Mehta, M. P., Kanner, A. A., & Ahluwalia, M. S. (2016). Future Directions for Tumor Treating Fields. In Alternating Electric Fields Therapy in Oncology (pp. 117–126). Springer International Publishing. https://doi.org/10.1007/978-3-319-30576-9_10
Mendeley helps you to discover research relevant for your work.